Black Box Warning for Botox The FDA announced today that it will require black box labeling on Botox and similar products warning of a rare, but potentially life threatening complication when the effects of the toxin spread far beyond the injection site.
FDA Approves New Wrinkle Treatment The FDA has approved Dysport to treat forehead wrinkles and frown lines, making it only the second drug to be approved by the agency as a wrinkle treatment.
Botox Rival Fades Frown Lines Treatments with Reloxin, a drug similar to Botox, can quickly improve frown lines and may keep them at bay for more than a year, a new study shows.
FDA Panel: Toughen Dermal Filler Warnings Dermal fillers injected to soften facial wrinkles should carry stronger and more specific warning labels about potential adverse effects, according to an FDA advisory panel.
Banishing Facial Wrinkles With Fillers Next to Botox, the most popular nonsurgical way to freshen up your looks is with a so-called "soft tissue" filler, often relied on to smooth away the nose-to-mouth line called the nasolabial or nasal labial fold.
FDA Checks Reports of Botox Risks The FDA says it's investigating reports of serious adverse events including death and respiratory failure linked with Botox, Botox Cosmetic, and Myobloc.
Who's Using Botox and Why? Starlets and superstars aren't the typical users of Botox, says the American Society for Aesthetic Plastic Surgery.